LordsMed Launches Diagnostics Exports

156

Starts With Nepal, Keen Expand Footprint

Delivering quality IVD solutions at a reduced cost, LordsMed has built a vast network of over 300 distributor channels across India

MUMBAI, July 19 (The CONNECT) –  LordsMed, the global healthcare division of Lord’s Mark Industries Pvt. Ltd. said it commenced exports of diagnostic supplies to Nepal. The company aims to establish itself as a leading global player in In-Vitro Diagnostics (IVD) manufacturing and export.

With a strong commitment to delivering quality IVD solutions at a reduced cost, LordsMed has successfully built a vast network of over 300 distributor channels across India. The manufacturing facilities located in the outskirts of Mumbai, currently has the capacity to facilitate an impressive 1.7 crore diagnostic tests per month, covering a wide range of specialties including biochemistry, haematology, serology, rapid tests, and urine strip tests.

Manav Teli, Executive Director, Lord’s Mark Industries said this marks a significant milestone in the company’s journey towards meeting the healthcare needs of a wider population

As Lord’s Mark Industries continues to strengthen its presence in the Indian market, the company is now strategically focusing on supplying neighbouring countries with its high-quality IVD products. The conglomerate currently has five companies: LordsMed, Lord’s Mark Biotech, Lord’s Mark Microbiotech, Brahamastra Defense Techno Products Limited, Lord’s Mark Insurance Broking Limited, and Lord’s Automative Private Limited, with other verticals in renewable energy products and paper.